Ryan Maynard

(Mr. Ryan Maynard)

Currently holds a position at Iovance Biotherapeutics Inc

Positions

Position Company Period
Independent Director Iovance Biotherapeutics Inc Feb. 16, 2015 -
Chief Financial Officer and Executive Vice President Rigel Pharmaceuticals Inc March 1, 2010 - Dec. 31, 2017
Ryan Maynard's trades of Iovance Biotherapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-12
S Sale
50,000 -87.0%
10.06
USD 503,000 		50,000 -87.0% 10.06 USD 503,000
2024-02-12 2023-02-08
PS Planned sale
5,488 -40.7%
0.53
USD 2,909 		5,488 -40.7% 0.53 USD 2,909
2022-06-02 2022-05-31
B Purchase
7,500 +inf%
6.75
USD 50,588 		7,500 +inf% 6.75 USD 50,588
// ... existing code ... // ... rest of the file ...